Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Immunogenicity and protective efficacy of recombinant Haemophilus parasuis SH0165 putative outer membrane proteins.

Fu S, Zhang M, Xu J, Ou J, Wang Y, Liu H, Liu J, Chen H, Bei W.

Vaccine. 2013 Jan 2;31(2):347-53. doi: 10.1016/j.vaccine.2012.11.003. Epub 2012 Nov 10.

PMID:
23149270
2.

Evaluation of recombinant proteins of Haemophilus parasuis strain SH0165 as vaccine candidates in a mouse model.

Yuan F, Fu S, Hu J, Li J, Chang H, Hu L, Chen H, Tian Y, Bei W.

Res Vet Sci. 2012 Aug;93(1):51-6. doi: 10.1016/j.rvsc.2011.04.020. Epub 2011 May 18.

PMID:
21596404
3.

Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5.

Zhou M, Guo Y, Zhao J, Hu Q, Hu Y, Zhang A, Chen H, Jin M.

Vaccine. 2009 Aug 20;27(38):5271-7. doi: 10.1016/j.vaccine.2009.06.051. Epub 2009 Jul 1.

PMID:
19576561
4.

The live attenuated Actinobacillus pleuropneumoniae triple-deletion mutant ΔapxIC ΔapxIIC ΔapxIV-ORF1 strain, SLW05, Immunizes pigs against lethal challenge with Haemophilus parasuis.

Fu S, Ou J, Zhang M, Xu J, Liu H, Liu J, Yuan F, Chen H, Bei W.

Clin Vaccine Immunol. 2013 Feb;20(2):134-9. doi: 10.1128/CVI.00458-12. Epub 2012 Dec 5.

5.

Construction and immune effect of Haemophilus parasuis DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mice.

Fu S, Zhang M, Ou J, Liu H, Tan C, Liu J, Chen H, Bei W.

Vaccine. 2012 Nov 6;30(48):6839-44. doi: 10.1016/j.vaccine.2012.09.014. Epub 2012 Sep 18.

PMID:
23000128
6.

Cross-protective efficacy of recombinant transferrin-binding protein A of Haemophilus parasuis in guinea pigs.

Huang X, Li Y, Fu Y, Ji Y, Lian K, Zheng H, Wei J, Cai X, Zhu Q.

Clin Vaccine Immunol. 2013 Jun;20(6):912-9. doi: 10.1128/CVI.00621-12. Epub 2013 Apr 24.

7.

Development and characterization of protective Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin and comparison with other subunit and commercial vaccines.

Frandoloso R, Martínez S, Rodríguez-Ferri EF, García-Iglesias MJ, Pérez-Martínez C, Martínez-Fernández B, Gutiérrez-Martín CB.

Clin Vaccine Immunol. 2011 Jan;18(1):50-8. doi: 10.1128/CVI.00314-10. Epub 2010 Oct 6.

8.

Identification of secreted proteins as novel antigenic vaccine candidates of Haemophilus parasuis serovar 5.

Li M, Song S, Yang D, Li C, Li G.

Vaccine. 2015 Mar 30;33(14):1695-701. doi: 10.1016/j.vaccine.2015.02.023. Epub 2015 Feb 20.

PMID:
25704800
9.

Systemic antibody response in colostrum-deprived pigs experimentally infected with Haemophilus parasuis.

Martín de la Fuente AJ, Rodríguez-Ferri EF, Frandoloso R, Martínez S, Tejerina F, Gutiérrez-Martín CB.

Res Vet Sci. 2009 Apr;86(2):248-53. doi: 10.1016/j.rvsc.2008.07.017. Epub 2008 Sep 9.

PMID:
18783805
10.

Soluble expression of OmpA from Haemophilus parasuis in Escherichia coli and its protective effects in the mouse model of infection.

Ahn J, Hong M, Yoo S, Lee E, Won H, Yoon I, Jung JK, Lee H.

J Microbiol Biotechnol. 2012 Sep;22(9):1307-9.

11.

Immunogenicity and protection against Haemophilus parasuis infection after vaccination with recombinant virulence associated trimeric autotransporters (VtaA).

Olvera A, Pina S, Pérez-Simó M, Aragón V, Segalés J, Bensaid A.

Vaccine. 2011 Mar 24;29(15):2797-802. doi: 10.1016/j.vaccine.2011.01.105. Epub 2011 Feb 12.

PMID:
21320547
12.

Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates.

Chang YF, Chen CS, Palaniappan RU, He H, McDonough SP, Barr SC, Yan W, Faisal SM, Pan MJ, Chang CF.

Vaccine. 2007 Nov 23;25(48):8190-7. Epub 2007 Sep 29.

PMID:
17936448
13.

Genomic and antigenic characterization of monomeric autotransporters of Haemophilus parasuis: an ongoing process of reductive evolution.

Pina-Pedrero S, Olvera A, Pérez-Simó M, Bensaid A.

Microbiology. 2012 Feb;158(Pt 2):436-47. doi: 10.1099/mic.0.052399-0. Epub 2011 Nov 10.

PMID:
22075024
14.

Identification of the immunogenic outer membrane protein A antigen of Haemophilus parasuis by a proteomics approach and passive immunization with monoclonal antibodies in mice.

Tian H, Fu F, Li X, Chen X, Wang W, Lang Y, Cong F, Liu C, Tong G, Li X.

Clin Vaccine Immunol. 2011 Oct;18(10):1695-701. doi: 10.1128/CVI.05223-11. Epub 2011 Aug 10.

15.

Production and characterization of murine monoclonal antibodies against Haemophilus parasuis and study of their protective role in mice.

Tadjine M, Mittal KR, Bourdon S, Gottschalk M.

Microbiology. 2004 Dec;150(Pt 12):3935-45.

PMID:
15583147
16.

Virulence and draft genome sequence overview of multiple strains of the swine pathogen Haemophilus parasuis.

Brockmeier SL, Register KB, Kuehn JS, Nicholson TL, Loving CL, Bayles DO, Shore SM, Phillips GJ.

PLoS One. 2014 Aug 19;9(8):e103787. doi: 10.1371/journal.pone.0103787. eCollection 2014.

17.

Characterization and Vaccine Potential of Outer Membrane Vesicles Produced by Haemophilus parasuis.

McCaig WD, Loving CL, Hughes HR, Brockmeier SL.

PLoS One. 2016 Mar 1;11(3):e0149132. doi: 10.1371/journal.pone.0149132. eCollection 2016.

18.

Molecular cloning, sequencing, and expression of the outer membrane protein P2 gene of Haemophilus parasuis.

Li P, Bai J, Li JX, Zhang GL, Song YH, Li YF, Wang XW, Jiang P.

Res Vet Sci. 2012 Oct;93(2):736-42. doi: 10.1016/j.rvsc.2011.08.019. Epub 2011 Sep 25.

PMID:
21945800
19.

Virulence-associated trimeric autotransporters of Haemophilus parasuis are antigenic proteins expressed in vivo.

Olvera A, Pina S, Pérez-Simó M, Oliveira S, Bensaid A.

Vet Res. 2010 May-Jun;41(3):26. doi: 10.1051/vetres/2009074. Epub 2009 Dec 10.

20.

Protection of piglets by a Haemophilus parasuis ghost vaccine against homologous challenge.

Hu M, Zhang Y, Xie F, Li G, Li J, Si W, Liu S, Hu S, Zhang Z, Shen N, Wang C.

Clin Vaccine Immunol. 2013 Jun;20(6):795-802. doi: 10.1128/CVI.00676-12. Epub 2013 Mar 27.

Items per page

Supplemental Content

Write to the Help Desk